Buy Dabibrook 150 mg (Dabigatran) – Anticoagulant for Stroke & Blood Clot Prevention

Dabibrook 150 mg contains dabigatran etexilate mesylate, a direct thrombin inhibitor manufactured by Healing Pharma (India). It’s prescribed to prevent stroke and systemic embolism in non‑valvular atrial fibrillation and to treat or prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). 

How It Works

Dabigatran directly inhibits thrombin, blocking clot formation even in existing fibrin-bound thrombin—helping prevent propagation of clots and reducing the risk of stroke and embolism.

Indications & Benefits

• Prevents stroke and blood clots in patients with non‑valvular atrial fibrillation. 
• Treats and prevents recurrence of DVT and PE in adults. Also used post‑hip/knee replacement surgery to prevent clots.
• Available as fixed-dose 150 mg capsules, taken twice daily—no routine monitoring required.

Dosage & Administration

• Typical adult dose: 150 mg twice daily, with or without food, at the same time each day. Capsules should be swallowed whole—do not crush or chew.
• Continue therapy as instructed—often long-term. Do not change dose or discontinue without physician guidance. 

Side Effects & Safety

• Common: gastrointestinal upset (dyspepsia, nausea, heartburn), stomach pain, diarrhea, bleeding or bruising. 
• Serious: major bleeding (gastrointestinal or cerebral), spinal or epidural hematoma with central neuraxial blockade, allergic reactions. Seek immediate medical attention for bleeding signs.
• Reversal agent: idarucizumab is available for life-threatening bleeding or urgent surgery. 

Precautions & Interactions

• Contraindications: active major bleeding, mechanical prosthetic heart valves, hypersensitivity. Avoid if moderate‐strong P‑gp inducers/ inhibitors reduce efficacy/toxicity. 
• Drug interactions: avoid combining with other anticoagulants, NSAIDs, antiplatelets (aspirin, clopidogrel) due to heightened bleeding risk. Monitor closely. 
• Caution in severe renal impairment (CrCl <30 mL/min), pregnancy, or women breastfeeding. Elderly may require dose adjustments.
• Do not stop suddenly—risk of rebound clotting increases. Consult doc before interruption. 

Global Availability & Prescription Info

Dabibrook 150 mg is prescription-only. Manufactured by Healing Pharma in India and available globally via licensed pharmacies with discreet shipping and tracking. Medical supervision is essential for safe anticoagulation.

📌 Frequently Asked Questions (FAQs)

1. What conditions does Dabibrook treat?

It prevents stroke and systemic embolism in non-valvular atrial fibrillation and treats/prevents DVT and PE in adults, including post‑surgery. 

2. What is the dosing schedule?

150 mg twice daily with or without food. Capsules must be swallowed whole. Do not double up if a dose is missed—resume at next scheduled time.

3. What side effects may occur?

Common: indigestion, nausea, stomach upset, diarrhea, easy bruising or bleeding. Rare but serious: gastrointestinal or cerebral hemorrhage, or spinal/epidural bleeding. 

4. Can dabigatran be reversed if bleeding occurs?

Yes—idarucizumab is a specific reversal agent used in case of severe or life‑threatening bleeding or urgent surgery.

5. What should I avoid while taking it?

Avoid concurrent use of NSAIDs, antiplatelets, other anticoagulants, or herbal supplements unless approved by your doctor, due to increased bleeding risk. Do not stop therapy suddenly.